Patented Medicine Prices
Review Board

The Requirement:

PMPRB ensures that the prices of patented medicines sold in Canada are not excessive. PMPRB requires patentees to report prices to them for review. Traditionally, this process has been accomplished manually with patentees providing their information in different formats.

The Solution

Pixelera helped standardize the reporting process by creating a drug reporting database that validates data submitted by patentees to ensure all required information has been provided.